Why Oral Dissolvable плёнка (ОРД) Products Are Gaining Popularity — Market Trends Technical Barriers

In recent years, oral dissolvable films (ODFs) have evolved from a “new dosage form exploration” to a critical product format crossing the фармацевтический, nutraceutical, and consumer goods sectors.

From over 10 FDA-approved ОРД drugs in the United States to the explosive growth of vitamin films and pediatric fever-reducing films in Asian markets, ODFs are becoming the next hot spot for dosage form innovation and technical competition.

---

1. Why Is the Market Bullish on ODFs?

• No swallowing required — Ideal for elderly and pediatric patients. ODFs can be placed on the tongue or oral mucosa, dissolving in saliva, making them perfect for people with dysphagia or nausea.
• Rapid onset & high bioavailability — Drugs can be absorbed directly through the oral mucosa, bypassing first-pass metabolism in the liver, resulting in faster onset and lower dosage.
• No water needed & highly portable — Ideal for hiking, travel, or long journeys; widely developed as an alternative dosage form during the COVID-19 period.
• High innovation appeal — Many ОРД products leverage TikTok, Xiaohongshu, and other platforms to attract younger consumers and new brands.

---

2. ОРД Market Growth данные

• The global ОРД market is expected to surpass USD 5 billion in 2024 and exceed USD 9 billion by 2028.
• Asia’s CAGR is over 17%, with China, Japan, and India being the primary growth regions.
• The nutraceutical sector’s “Blue Hat” плёнка registration trend is rising, with multiple successful registrations already achieved.

---

3. ОРД’s Technical Barriers Are Higher Than They Appear

Although they look like a “thin sticker,” ODFs are actually a sophisticated integration of formulation and производство technology:

• плёнка base development challenges — Balancing solubility, mechanical strength, and stability.
• Stringent покрытие требования — With покрытие thickness of just 0.1–0.3 mm, even slight unevenness can affect dosage accuracy. Our MJ150 High-Capacity ОРД покрытие System and MJ150-L лаб-Scale ОРД покрытие System deliver ±0.02 mm precision.
• Advanced drying systems — Temperature, humidity, and tension control determine if the final product resists curling, deformation, or moisture absorption.
• Integrated packaging — стандарт packaging машины are insufficient; ODFs require cutting, defect removal, and sealing. Our MJF180 Cutting & Packaging машина integrates these steps for GMP соответствие.

---

Conclusion

ODFs are not just a new dosage form — they represent a user-centric innovation philosophy. From фармацевтические and nutraceuticals to functional foods and even pet добавки, ODFs are unlocking new possibilities.

The future belongs to teams that understand both formulation development and производство technology. At HUANGHAI, we combine оборудование innovation with R&D collaboration to help clients achieve true commercialization.

*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.

---

Frequently Asked Questions

Q: What pharmacopoeial стандарт governs тестирование растворения?

A: тестирование растворения is governed by USP <711> (United States Pharmacopeia), ChP 0931 (Chinese Pharmacopoeia), and Ph.Eur. 2.9.3 (European Pharmacopoeia). All Huanghai RCZ-series растворение testers are designed to comply with USP <711> paddle and basket methods, meeting the ±0.5 rpm speed tolerance and ±0.5°C temperature control требования. For international market access, verify which pharmacopoeia your target regulatory body recognizes.

Q: How many растворение channels do I need for a КК лаб?

A: Channel selection depends on your batch size and тестирование throughput. A 6-channel tester (RCZ-6N) suits small-volume labs running one formulation at a time. An 8-channel tester (RCZ-8A) accommodates USP <711> 6-vessel runs with 2 spares. A 12-channel tester (RCZ-12A) is ideal for high-throughput labs running two products simultaneously. As a rule: choose at minimum 8 channels for routine КК; upgrade to 12 if you have more than 3 active products in КК тестирование. Contact us for pricing.

Q: What is the difference between syringe pump and peristaltic pump in automated sampling?

A: Syringe pumps (used in Huanghai RCZ-QY series) deliver precise, pulsation-free sample withdrawal—critical for viscous media or flow-sensitive APIs. Peristaltic pumps are lower cost but introduce pulsation artifacts that can affect UV absorbance readings in inline detection. For validated methods submitted to regulatory agencies, syringe-pump systems such as the RCZ-QY12 are preferred because they demonstrate superior reproducibility in audit-trail-backed данные.

Q: Does the тестер растворения support FDA 21 CFR Part 11 соответствие?

A: Huanghai intelligent растворение testers (RCZ-8N, RCZ-12A, RCZ-QY series) include журнал аудита functionality—timestamped records of all parameter changes and operator actions—meeting basic USP and ChP журнал аудита требования. However, they are not certified as fully 21 CFR Part 11 compliant because certain parameters remain modifiable for R&D flexibility. For FDA-regulated КК environments, pair the instrument with a validated LIMS or лаборатория software stack to achieve full Part 11 соответствие. Contact us to discuss соответствие configuration for your specific regulatory submission.

Q: How often should растворение media be degassed before тестирование?

A: USP <711> recommends degassing растворение media immediately before use to remove dissolved oxygen that can cause bubble formation on таблетка surfaces—leading to false-low растворение results. Best practice: degas each media batch within 30 minutes of тестирование. The HTQ-1A вакуумный дегазатор processes up to 25 liters in a single cycle using vacuum + UV sterilization, eliminating microbial contamination risk. For labs running 8–12 channel testers, a dedicated degasser prevents throughput bottlenecks between runs.